This document is an excerpt from the EUR-Lex website
Document 52005XC1230(03)R(01)
Corrigendum to the Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005 ( OJ C 334, 30.12.2005 )
Corrigendum to the Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005 ( OJ C 334, 30.12.2005 )
Corrigendum to the Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005 ( OJ C 334, 30.12.2005 )
IO C 46, 24.2.2006, p. 33–33
(ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, NL, PL, PT, SK, SL, FI, SV)
|
24.2.2006 |
EN |
Official Journal of the European Union |
C 46/33 |
Corrigendum to the Summary of Community decisions on marketing authorizations in respect of medicinal products from 20 November 2005 to 30 November 2005
( Official Journal of the European Union C 334 of 30 December 2005 )
(2006/C 46/09)
On page 45:
for:
‘Pfizer Ltd.’
read:
‘Pharmacia Ltd.’.